From foes to friends: rethinking the role of lymph nodes in prostate cancer out on @NatRevUrol
https://t.co/wMsdKISoCU
The therapeutic value of lymph node removal in prostate cancer treatment is debated, as while it aids in disease staging, it may reduce the effectiveness of immunotherapies by disrupting immune activation at tumor-draining lymph nodes.
Out by researchers from @IcahnMountSinai
Ping: @bavilima@nataliagandur@yekeduz_emre
Optilume has changed my stricture practice. I've done the balloon dilation without fluoro using a flexible cystoscope for many years but I'm having fewer recurrences now with DCB. will there be less need for @SocietyGURS? https://t.co/N5aPXbbEW9 via @YouTube
Single-port Trans-vesical Radical Prostatectomy with modified Hood Technique. Much thanks to @drjkaouk and @AshTewariMD for paving the path. Looking forward to SPARC meeting @AmerUrological#AUA24
✅ retzius-sparing
✅ nerve sparing with preservation of anterior structures
Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’
Terminando de leer el artículo que salió ayer y que sería la revisión más grande hasta ahora en relación con el consumo de jugo de fruta 100% y exceso de peso.
Avalaría la recomendación actual de evitar tomar jugos, así sean 100%, sobre todo en niños. Más tarde hago un Reel.
It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2023: Some negative, some positive, but we learned from all!
Feel free to add more & retweet & tag
This is not an exhaustive list!
@OncoAlert@danafarber@DanaFarber_GU#OnwardFor2024